[Renal action of vasopressin].
Sasaki
Masami
M
Department of Medicine, Jichi Medical School Omiya Medical Center.
Ishikawa
San-e
SE
D000818:Animals; D065092:Antidiuretic Hormone Receptor Antagonists; D051399:Aquaporin 2 / Q000235:genetics / Q000502:physiology; D001127:Arginine Vasopressin / Q000096:biosynthesis / Q000378:metabolism / Q000502:physiology; D001552:Benzazepines / Q000494:pharmacology / Q000627:therapeutic use; D003919:Diabetes Insipidus / Q000209:etiology; D018500:Diabetes Insipidus, Nephrogenic / Q000209:etiology; D015195:Drug Design; D006801:Humans; D007010:Hyponatremia / Q000188:drug therapy / Q000209:etiology; D007177:Inappropriate ADH Syndrome / Q000209:etiology; D009154:Mutation; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use; D015363:Quinolones / Q000494:pharmacology / Q000627:therapeutic use; D017483:Receptors, Vasopressin / Q000737:chemistry / Q000235:genetics / Q000502:physiology
C496023:AQP2 protein, human; D065092:Antidiuretic Hormone Receptor Antagonists; D051399:Aquaporin 2; D001552:Benzazepines; D010880:Piperidines; D015363:Quinolones; D017483:Receptors, Vasopressin; D001127:Arginine Vasopressin; C068644:OPC 21268; C076251:mozavaptan